Xenetic Biosciences Inc (XBIO)
3.776
-0.07
(-1.92%)
USD |
NASDAQ |
Apr 25, 16:00
3.77
-0.01
(-0.16%)
After-Hours: 20:00
Xenetic Biosciences Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2019 | 16.13M |
| September 30, 2019 | 16.13M |
| June 30, 2019 | 2.700M |
| March 31, 2019 | 4.179M |
| December 31, 2018 | 1.48M |
| September 30, 2018 | 1.48M |
| June 30, 2018 | 1.48M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 8.462M |
| June 30, 2017 | 9.462M |
| March 31, 2017 | 9.457M |
| December 31, 2016 | 12.72M |
| September 30, 2016 | 4.258M |
| June 30, 2016 | 6.158M |
| Date | Value |
|---|---|
| March 31, 2016 | 6.263M |
| December 31, 2015 | 3.00M |
| September 30, 2015 | 3.00M |
| June 30, 2015 | -0.1861M |
| March 31, 2015 | -0.2861M |
| December 31, 2014 | 9.816M |
| September 30, 2014 | 9.976M |
| June 30, 2014 | 10.26M |
| March 31, 2014 | 10.26M |
| November 30, 2013 | 0.16M |
| August 31, 2013 | 0.00 |
| May 31, 2013 | 0.00 |
| February 28, 2013 | 0.035M |
| November 30, 2012 | 0.035M |
| August 31, 2012 | 0.035M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
2.700M
Minimum
Jun 2019
16.13M
Maximum
Dec 2019
11.65M
Average
16.13M
Median
Sep 2019
Cash from Financing (TTM) Benchmarks
| Perspective Therapeutics Inc | 0.785M |
| Electromed Inc | -0.128M |
| Xtant Medical Holdings Inc | 19.69M |
| Asensus Surgical Inc | 9.626M |
| Myomo Inc | 9.714M |